CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue4,822.2722,440.1951,911.424648.382
Cost of Revenue48,613.95726,038.96515,436.7355,888.659
Gross Profit-43,791.685-23,598.77-13,525.311-5,240.277
Operating Expenses
Research Development----
Selling General and Administrative12,956.0228,964.0466,459.7473,613.416
Non Recurring----
Others----
Total Operating Expenses61,569.97935,003.01121,896.4829,502.075
Operating Income or Loss-56,747.707-32,562.816-19,985.058-8,853.693
Income from Continuing Operations
Total Other Income/Expenses Net1,075.568141.204-13.6172.954
Earnings Before Interest and Taxes-56,747.707-32,562.816-19,985.058-8,853.693
Interest Expense-7.431-9.743-4.401-2.44
Income Before Tax-55,672.139-32,421.612-19,998.675-8,850.739
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-55,672.139-32,421.612-19,998.675-8,850.739
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-55,672.139-32,421.612-19,998.675-8,850.739
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-55,672.139-32,421.612-19,998.675-8,850.739